Press Releases - 2023-11-17

Date	Title	Company
17-Nov-2023	Contraceptive services to be expanded under Pharmacy First scheme, PAGB response	The Department for Health and Social Care (DHSC)
17-Nov-2023	Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in cardiovascular disease, says GlobalData	Verve Therapeutics
17-Nov-2023	‘Rheumacensus’ experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements	UCB
17-Nov-2023	POLB 001 LPS Challenge Trial Data to be Presented at IUIS	Poolbeg Pharma plc
17-Nov-2023	Versameb AG Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence	Versameb AG
17-Nov-2023	Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in US Phase 3 clinical trial, CALYX	Minoryx
17-Nov-2023	Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards	Amolyt Pharma
17-Nov-2023	Berry's PneumoHaler Enables Better Patient Administration and Speed-to-Market	Berry Global Healthcare
17-Nov-2023	Researchers uncover role of ‘molecular plasters’ that protect against infection	Francis Crick Institute
17-Nov-2023	Ori Biotech LEAPs forward toward commercialization in 2024	Ori Biotech
17-Nov-2023	Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors	Myricx Bio
17-Nov-2023	Tessellate BIO, an Emerging Precision Oncology Company Announces the Appointment of World-Leading Scientists to its Scientific Advisory Board	Tessellate BIO
17-Nov-2023	Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis	XBiotech
17-Nov-2023	CoverSelf extends seed round to $8.2m with renewed interest from existing investors, leading healthcare leaders and entrepreneurs	CoverSelf
17-Nov-2023	bioProcessUK to celebrate biotech’s shining stars	The BioIndustry Association (BIA)
17-Nov-2023	Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in US Phase 3 clinical trial, CALYX	Minoryx
17-Nov-2023	UK industry clinical trial performance shows signs of improvement, says ABPI report	ABPI
17-Nov-2023	Oncology Nutrition Market Envisions Cultivating Wellness, Poised at US$4.79 Billion by 2032-FMI Reports	MARKITWIRED
17-Nov-2023	Acute Kidney Injury Treatment Market Aims for a Noteworthy Valuation of US$ 3,566.7 Million by 2029-FMI Study	MARKITWIRED
17-Nov-2023	Mortuary Bag Market Poised to Attain a Valuation of US$656.61 Million by 2033-FMI Study	MARKITWIRED